Pirrolopirimidina derived compounds as inhibitors of kinases； Pharmaceutical composition that is useful for the treatment of a disease or autoimmune conditions such as rheumatoid arthritis or lupus, and for the treatment of a disease or condition heteroinmune or inflamatori To.
Disclosed herein are compounds exemplified by the following structure Formula (I) that form covalent bonds with Bruton's tyrosine kinase (Btk). Also disclosed are pharmaceutical compositions that include the compounds of Formula (I). Methods of using the Btk inhibitors exemplified by the structure of Formula (I) are disclosed, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.<；p>；COMPUESTOS DERIVADOS DE 4-AMINO-5-FENILO-7H-PIRROLO[2,3-D]-PIRIMIDINA, INHIBIDORES REVERSIBLES E IRREVERSIBLES DE Btk； COMPOSICIÓ；N FARMACÉ；UTICA； Ú；TILES PARA EL TRATAMIENTO DE ENFERMEDADES AUTOINMUNES, TALES COMO ARTRITIS REUMATOIDE, LUPUS, CÁ；NCER, INCLUIDO EL LINFOMA Y ENFERMEDADES INFLAMATORIAS.<；/p>；
